Fish F A, Prakash C, Roden D M
Department of Pediatrics, Vanderbilt University, Nashville, Tenn. 37232-6602.
Circulation. 1990 Oct;82(4):1362-9. doi: 10.1161/01.cir.82.4.1362.
Marked prolongation of cardiac action potentials and of QT intervals has been associated with early afterdepolarizations and triggered activity in vitro and with ventricular tachycardia in vivo. Because the antihypertensive potassium channel activators pinacidil and cromakalim are known to accelerate repolarization in cardiac tissues, we performed in vitro and in vivo experiments to test the hypothesis that these agents would block the arrhythmogenic effects of delayed repolarization. Early afterdepolarizations and triggered activity were elicited in canine cardiac Purkinje fibers driven at cycle lengths of 4 seconds or more (K0, 2.7 mM) during superfusion with quinidine, cesium, or sematilide, a methylsulfonylamino parasubstituted analogue of procainamide with class III antiarrhythmic activity. The potassium channel activators invariably (17 of 17) abolished this form of abnormal automaticity. This effect was observed at low concentrations that did not alter action potential characteristics at shorter cycle lengths. Intravenous Cs+ (total dose, 4.5 mM/kg) was used to produce ventricular arrhythmias in anesthetized rabbits randomly pretreated in a double-blind fashion with either low-dose pinacidil (0.2 mg/kg) or vehicle. Pinacidil pretreatment resulted in significantly fewer total ventricular ectopic beats (168 +/- 157 versus 582 +/- 448, p less than 0.005) and episodes of ventricular tachycardia (four of nine versus nine of nine, p = 0.057). At this dose, pinacidil did not alter mean blood pressure before Cs+ and maximal hypertensive response after Cs+. In summary, the potassium channel activators pinacidil and cromakalim suppressed triggered activity related to prolonged repolarization at concentrations that did not affect action potential characteristics at normal rates in vitro; pinacidil blunted arrhythmias produced by cesium administration in vivo without lowering blood pressure.(ABSTRACT TRUNCATED AT 250 WORDS)
心脏动作电位和QT间期的显著延长与早期后除极以及体外触发活动和体内室性心动过速有关。由于已知降压钾通道激活剂吡那地尔和克罗卡林可加速心脏组织的复极化,我们进行了体外和体内实验,以检验这些药物会阻断延迟复极化致心律失常作用的假说。在用奎尼丁、铯或塞他利定(一种具有Ⅲ类抗心律失常活性的对氨基苯磺酰氨基对位取代的普鲁卡因酰胺类似物)灌流期间,以4秒或更长的周期长度(K0,2.7 mM)驱动犬心脏浦肯野纤维,引发早期后除极和触发活动。钾通道激活剂无一例外地(17例中的17例)消除了这种形式的异常自律性。在不改变较短周期长度时动作电位特征的低浓度下观察到了这种效应。静脉注射Cs +(总剂量,4.5 mM/kg)用于在随机以双盲方式用低剂量吡那地尔(0.2 mg/kg)或赋形剂预处理的麻醉兔中诱发室性心律失常。吡那地尔预处理导致总的室性异位搏动明显减少(168±157对582±448,p<0.005)和室性心动过速发作减少(9只中的4只对9只中的9只,p = 0.057)。在此剂量下,吡那地尔在注射Cs +之前不改变平均血压,在注射Cs +之后也不改变最大高血压反应。总之,钾通道激活剂吡那地尔和克罗卡林在体外不影响正常速率下动作电位特征的浓度时,抑制了与复极化延长相关的触发活动;吡那地尔在体内减弱了由铯给药产生的心律失常,而不降低血压。(摘要截短于250字)